Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1GNJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,779
Award facts
- Contract value 100% obligated
- $20,779.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $20,779.17 on January 30, 2026, for the supply of Dupixent 300 mg/2 ml pen injections (2 ml units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 2, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at up to $999,999,999.00 through December 2026 that provides comprehensive pharmaceutical and medical supply support for military healthcare systems globally.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal agencies including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated capability to fulfill federal medical procurement requirements through competitive awards across a broad portfolio of pharmaceutical products, including specialty medications, vaccines, and medical devices. This delivery order for Dupixent, a prescription immunosuppressant used to treat conditions such as atopic dermatitis and eosinophilic asthma, reflects AmerisourceBergen's ongoing role as a critical vendor for military medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F1GNJ?
SPE2DR26F1GNJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F1GNJ worth?
The government has obligated $20,779 on SPE2DR26F1GNJ.
Is contract SPE2DR26F1GNJ an order under another contract?
Yes. SPE2DR26F1GNJ is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GNJ competed?
The extent of competition for SPE2DR26F1GNJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award